Related Experiment Video
Updated: May 24, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Clinical features by disease duration in ulcerative colitis-associated cancers
Hiroshi Miyakita1, Seiichiro Yamamoto1, Motoi Uchino2
1Department of Surgery, Tokai University School of Medicine, Isehara, Japan.
Ulcerative colitis duration impacts colitis-associated cancer features, but not prognosis. Early diagnosis and specific histological types are more common with longer disease duration, though survival outcomes remain similar.
Area of Science:
- Gastroenterology
- Oncology
- Colorectal Surgery
Background:
- Ulcerative colitis (UC) is linked to colitis-associated cancer (CAC).
- CAC often presents as flat type, mucinous carcinoma, or signet ring cell carcinoma.
- The influence of UC duration on CAC outcomes requires further investigation.
Purpose of the Study:
- To investigate the effect of ulcerative colitis duration on the clinicopathological features of colitis-associated cancer.
- To analyze how disease duration influences diagnostic opportunities, histological types, and tumor characteristics in CAC.
Main Methods:
- Analysis of data from 1200 UC patients with colorectal cancer.
- Histological and clinicopathological features were examined.
- Comparisons were made using disease duration cutoffs of 5 and 15 years.
Main Results:
- Significant correlations were found between disease duration (0-5 vs. >5 years) and diagnostic opportunity, vascular invasion, N factor, pathological stage, and tumor location.
- Longer disease duration (>15 years) correlated with diagnostic opportunity and primary sclerosing cholangitis.
- Trend analysis revealed correlations between disease duration and diagnostic opportunity, histological type, vascular invasion, and tumor location.
Conclusions:
- Distinct histological and clinical features of CAC emerge with increasing UC duration.
- These features intensify over time but do not appear to significantly alter prognostic outcomes.
- Current findings suggest that differentiating between short-term and long-term disease duration may not be necessary for cancer treatment decisions.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Cancer Survival Analysis
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Drugs for Treatment of Ulcerative Colitis in IBD

